|
Volumn 10, Issue 6, 2004, Pages 531-537
|
Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RECOMBINANT ERYTHROPOIETIN;
AMBULATORY CARE;
ANEMIA;
ARTICLE;
BLOOD EXAMINATION;
BLOOD TRANSFUSION;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
COST;
COST CONTROL;
DRUG ADMINISTRATION;
DRUG COST;
ECONOMICS;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PROSPECTIVE STUDY;
ANEMIA;
ANTINEOPLASTIC AGENTS;
BLOOD TRANSFUSION;
COST CONTROL;
COSTS AND COST ANALYSIS;
DRUG ADMINISTRATION SCHEDULE;
DRUG COSTS;
EPOETIN ALFA;
FEMALE;
HEMATOLOGIC TESTS;
HUMANS;
MALE;
MIDDLE AGED;
OFFICE VISITS;
PROSPECTIVE STUDIES;
|
EID: 14544272966
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: 10.18553/jmcp.2004.10.6.531 Document Type: Article |
Times cited : (13)
|
References (0)
|